Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Continuous Chemotherapeutic Hyperthermic Peritoneal Perfusion

Known as: CHPP, continuous hyperthermic peritoneal perfusion 
A procedure that bathes the abdominal cavity in fluid that contains anticancer drugs. This fluid is warmer than body temperature. This procedure… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
A Phase I Trial of Oxaliplatin for Intraperitoneal Hyperthermic Chemoperfusion for the Treatment of Peritoneal Surface Dissemination from Colorectal and Appendiceal Cancers
BackgroundCytoreductive surgery with intraperitoneal hyperthermic chemoperfusion (IPHC) has evolved into a promising approach for… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination
Continuous hyperthermic peritoneal perfusion (CHPP) with anticancer agents (mitomycin C and cisplatin) in warm saline was… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: Randomized controlled study
We performed continuous hyperthermic peritoneal perfusion (CHPP) or continuous normothermic peritoneal perfusion (CNPP) combined… Expand
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver.
PURPOSE Liver metastases are the sole or life-limiting component of disease in the majority of patients with ocular melanoma who… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study.
BACKGROUND/AIMS Although the most frequent cause of death after curative resection of advanced gastric cancer is peritoneal… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Treatment of Primary Peritoneal Mesothelioma by Continuous Hyperthermic Peritoneal Perfusion (CHPP)
AbstractBackground: Primary peritoneal mesothelioma is a locally aggressive disease that is difficult to treat or even palliate… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination.
BACKGROUND The most common cause of noncurative resection and recurrence is gastric cancer is peritoneal seeding. However, the… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study.
BACKGROUND Continuous hyperthermic peritoneal perfusion (CHPP) with a solution that contained 10 micrograms/ml mitomycin C was… Expand
Is this relevant?
Highly Cited
1988
Highly Cited
1988
Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C.
Continuous hyperthermic peritoneal perfusion (CHPP) with a solution that contains mitomycin C (CHPP-M) has been clinically… Expand
Is this relevant?
Highly Cited
1984
Highly Cited
1984
Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug.
To study the feasibility of combined hyperthermic and anticancer drug treatment for peritoneal cancer, we devised a continuous… Expand
  • table 2
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE